Risk of Age-Related Macular Degeneration in Men Receiving 5α-Reductase Inhibitors: A Population-Based Cohort Study

July 2024 in “ Age and Ageing ”

Yu‐Chen Su, Chin‐Yao Shen, Shih‐Chieh Shao, Chi‐Chun Lai, Sheng-Min Hsu, Chaw‐Ning Lee, Chan-Jung Liu, Jia‐Horung Hung, Edward Chia‐Cheng Lai

5α-reductase inhibitors 5ARIs tamsulosin dutasteride finasteride androgen inhibition Propecia Avodart

TLDR Men taking dutasteride may have a higher risk of age-related macular degeneration.

This study investigated the risk of age-related macular degeneration (AMD) in men with benign prostate hyperplasia (BPH) using 5α-reductase inhibitors (5ARIs) or tamsulosin. Data from 13,586 5ARIs users and 54,344 tamsulosin users were analyzed over an average follow-up of 3.7 years. The results showed no significant difference in AMD risk between 5ARIs and tamsulosin users overall. However, subgroup analysis revealed an increased risk of AMD in patients taking dutasteride (HR: 1.13) but not in those taking finasteride (HR: 0.99). This suggests that the potency of androgen inhibition may influence AMD incidence.

View this study on doi.org →

Discuss this study in the Community →

Cited in this study

7 / 7 results

research Androgenetic Alopecia: Therapy Update

May 2023 in “Drugs”

There are many treatments for common hair loss, but more trials are needed to decide which are best.

research Macular Abnormalities Associated With 5α-Reductase Inhibitor

6 citations, May 2020 in “JAMA Ophthalmology”

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.

research Incidence of Type 2 Diabetes Mellitus in Men Receiving Steroid 5α-Reductase Inhibitors: Population-Based Cohort Study

29 citations, April 2019 in “BMJ. British medical journal”

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

research Association Between Male Pattern Baldness and Prostate Disease: A Meta-Analysis

7 citations, February 2018 in “Urologic Oncology: Seminars and Original Investigations”

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

research The Direct Inhibitory Effect of Dutasteride or Finasteride on Androgen Receptor Activity Is Cell Line Specific

12 citations, October 2013 in “The Prostate”

Dutasteride and finasteride affect different cell types differently.

research Marked Suppression of Dihydrotestosterone in Men with Benign Prostatic Hyperplasia by Dutasteride, a Dual 5α-Reductase Inhibitor

408 citations, May 2004 in “The Journal of clinical endocrinology and metabolism/Journal of clinical endocrinology & metabolism”

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

research Comparison of Clinical Trials with Finasteride and Dutasteride

20 citations, January 2004 in “PubMed”